Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines

Yun-Ho Choi(LG (South Korea)), Sang-Hwa Lee, Jae Young Shin(Jeonju University), Jaeyoon Kim(LG (United States)), Nae‐Gyu Kang(LG (United States))
European Journal of Pharmacology
January 5, 2022
Cited by 9


Related Papers